Proinflammatory cytokines — as a marker of the effectiveness of neuroprotection in children with perinatal nervous system damage
In patients with CNS ASD of varying severity, the inclusion of Cortexin in treatment regimens leads to a significant shift in IL-Iß and TNF-α levels 3 months after the start of treatment, which significantly exceeds the results of standard treatment.
Authors
- V.A. Drobyshev
- V.G. Degtyareva
Institutions
- Novosibirsk State Medical University (RU)
Publication Details
- Journal
- S S Korsakov Journal of Neurology and Psychiatry
- Published
- 2025-06-27
- DOI
- https://doi.org/10.17116/jnevro202512506162
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00